Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials

Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials

Andrea Casadei Gardini,1* Marco Puzzoni,2* Francesco Montagnani,3* Giorgia Marisi,4* Emiliano Tamburini,5 Alessandro Cucchetti,6,7 Leonardo Solaini,6,7 Francesco Giuseppe Foschi,8 Fabio Conti,8 Giorgio Ercolani,6,7 Stefano Cascinu,1 Mario Scartozzi21Division of Medical Oncology, Department of Medica...

Full description

Bibliographic Details
Main Authors: Casadei Gardini A, Puzzoni M, Montagnani F, Marisi G, Tamburini E, Cucchetti A, Solaini L, Foschi FG, Conti F, Ercolani G, Cascinu S, Scartozzi M
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:OncoTargets and Therapy
Subjects:
Sorafenib
hepatocellular carcinoma
randomized trial
biomarkers
erlotinib
linifanib
sunitinib
brivanib.
Online Access:https://www.dovepress.com/profile-of-lenvatinib-in-the-treatment-of-hepatocellular-carcinoma-des-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/profile-of-lenvatinib-in-the-treatment-of-hepatocellular-carcinoma-des-peer-reviewed-article-OTT

Similar Items